The British series Supacell, available on Netflix, uses sickle cell disease as a starting point to narrate a superhero story. Released in 2024, the work has achieved great success, and its second season is currently being edited for a premiere in early 2027. This fiction can serve as an effective medium to debate the fight for the rights of individuals affected by the disease.
Created by British director and screenwriter Andrew Onwubolu, the plot follows five young Black people from South London who acquire extraordinary abilities, such as teleportation, superhuman strength, and time travel, due to a genetic mutation related to the disease, without having developed the condition themselves.
In the first season, Michael Lasaki (played by Tosin Cole), a delivery driver, discovers the ability to go back in time and anticipates his girlfriend's murder. His search for other people with similar powers to save her places him in a conspiracy where a clandestine organization tries to dominate and imprison individuals endowed with superpowers.
However, the series transcends the archetype of the traditional superhero, who wears a cape and acts as a vigilante. The characters remain engaged in daily adversities, dealing with family, financial, violence, and relationship issues.
Sickle cell disease is hereditary and results from modifications in the gene responsible for producing hemoglobin, the molecule that transports oxygen in red blood cells. When there is oxygen deficiency, these red blood cells take a sickle shape, which can block microvessels and cause intense pain and severe inflammation. Although it is more common in populations of African descent in Brazil, this does not establish an exclusive link. The Ministry of Health estimates that between 60,000 and 100,000 people in the country live with this condition.
Despite using this genetic heritage as a potential strength, the Netflix series also addresses the racism inherent in this determinism. In a conversation, Andre Simpson (Eric Abrefa) recounts the death of AJ's grandfather (Ki-Many Carty), who was a victim of a stroke linked to the disease. Upon learning the cause, AJ questions whether the illness is exclusive to Black people, and his father clarifies that people of other ethnicities can also contract it, mentioning that both underwent tests.
Michael's mother is a central character who lives with the disease. In the initial episode, while she is hospitalized to stop a crisis, a representative from an organization offers services that promise faster and more efficient symptomatic control, but this advantage comes at a high cost.
This conflict brings the fiction closer to reality: the existence of effective treatments does not guarantee access to them. In Brazil, care depends on the availability of specialized services, medications, and professionals. In this context, the role of collectives and associations of people with sickle cell disease is crucial to ensuring treatment.
In 2006, the World Health Organization (WHO) endorsed a resolution requesting countries to consider sickle cell disease a public health problem. Research conducted in Brazil, starting in 2025, points to the existence of approximately 30 collectives and associations, most founded after the 2000s, driven by the National Policy for Comprehensive Care of People with Sickle Cell Disease (PNAIPDF) of 2005.
An article published in the journal História, Ciências, Saúde – Manguinhos analyzes Brazil's role in the international dissemination of the Unified Health System (SUS) and technical cooperation initiatives regarding sickle cell disease carried out between 2006 and 2010 with Benin, Ghana, and Senegal. The study demonstrates how Brazilian representatives presented a methodology focused on comprehensive care and continuous monitoring, something only viable in a universal and free healthcare system like SUS.
Brazil is recognized as a reference in research and in its care model, centered on Comprehensive Care. Because it is a chronic disease that requires permanent care, this model serves as an example for other nations. This view remains essential: care requires prevention, diagnosis, treatment, and continuous monitoring, with primary care articulating access to other services.
Among the main needs of patients with sickle cell disease are the continuous supply of medication, support during crises, and humanized care by specialists. This is not limited to Brazil, as observed during the 1st Portuguese Symposium on Sickle Cell Disease and Thalassemia, held in September of this year in Lisbon, with the presence of Portuguese activists.
Often, what is lacking is the adequate care routine: doctors who understand extreme fatigue and the pain caused by crises, and access to hydroxyurea. This medication stimulates the body to produce fetal hemoglobin, significantly reducing recurrent crises, although it does not replace bone marrow transplant, considered the main path to cure.
Although offered by SUS, the distribution of this drug is irregular because it depends on the priorities defined by state health policies, leaving it to the state government to regulate the supply.
Besides associations, there are prominent Brazilian activists on social media and recognized by Portuguese colleagues. A notable name is Simone Bruna, who maintains a YouTube channel focused on access to treatment, frequently highlighting the role of SUS. She used hydroxyurea for free for twenty years and, at 38, underwent a bone marrow transplant. Recently, she celebrated two years since the procedure, completed in October 2026, a period necessary to confirm bodily adaptation and the ability to generate healthy red blood cells.
Bone marrow transplant is the main curative method, but another obstacle arises: the limitation of beds. The restricted number of beds in the country forces people with various serious illnesses to compete for insufficient hospital infrastructure, resulting in the accumulation of sequelae due to constant crises while waiting.
In addition to hydroxyurea and transplantation, gene therapies have already been approved in certain countries. These techniques aim to alter cellular function to mitigate the effects of the genetic alteration, promoting the production of fetal hemoglobin. Despite promising results, they require complex procedures, specialized monitoring, and prolonged follow-up. Costs and the need for specialized centers can also restrict access, without replacing regular care, specialized attention, and access to medication.
In Supacell, the secret organization proposes teaching the protagonists to control their powers, but subjects them to a surveillance regime. The reality of medical research differs, and the development of new therapies represents a significant advance. Nevertheless, the narrative allows for reflection on who controls the resources capable of transforming lives and who actually benefits from them.
}))

